Could Therorna’s circRNA in vivo CAR-T platform change autoimmune disease treatment?
CAR-T is powerful but hard to scale. Therorna’s circRNA platform tests whether in vivo engineering can move the field beyond bespoke therapy.
Pharma & Biotech